Borosil Scientific Ltd Valuation Shifts Amid Market Volatility

Valuation Metrics Signal Elevated Pricing

As of 13 Feb 2026, Borosil Scientific trades at a P/E ratio of 43.14, a significant premium compared to its historical averages and peer group benchmarks. This multiple places the stock firmly in the "expensive" category, a shift from its previous "fair" valuation status. The price-to-book value ratio has also risen to 2.56, indicating that investors are paying more than double the company's net asset value for each share.

Other enterprise value (EV) based multiples reinforce this trend. The EV to EBIT ratio stands at 33.79, while EV to EBITDA is 19.90, both considerably higher than many peers in the industrial products sector. For context, Saint-Gobain Sekurit, a comparable company, trades at a P/E of 21.82 and EV/EBITDA of 15.90, categorised as "very expensive" but still notably cheaper than Borosil Scientific. Meanwhile, Empire Industries and Haldyn Glass offer "very attractive" valuations with P/E ratios of 15.41 and 24.95 respectively, and EV/EBITDA multiples well below Borosil’s.

Financial Performance and Returns Underpin Valuation Concerns

Underlying these valuation concerns are Borosil Scientific’s modest returns on capital. The latest reported return on capital employed (ROCE) is 6.91%, while return on equity (ROE) is 4.53%. These figures lag behind industry averages and do not justify the elevated multiples from a fundamental perspective. The absence of dividend yield further diminishes the stock’s appeal for income-focused investors.

Price action has been volatile but generally positive in the short term, with the stock price rising 10.12% on the day of reporting and a one-week return of 9.91%, significantly outperforming the Sensex’s 0.43% gain over the same period. However, longer-term returns tell a different story. The stock has declined 17.41% over the past year, contrasting sharply with the Sensex’s 9.85% gain. Year-to-date, Borosil Scientific is down 3.0%, slightly underperforming the benchmark index’s 1.81% decline.

Comparative Analysis Highlights Relative Overvaluation

When compared with its peer group, Borosil Scientific’s valuation premium appears unjustified. Several competitors in the industrial products sector offer more compelling valuations and stronger fundamentals. For instance, Empire Industries and Haldyn Glass, both rated as "very attractive," trade at substantially lower P/E and EV/EBITDA multiples, suggesting better price-to-earnings and operational cash flow metrics. Additionally, companies like Jai Mata Glass and Triveni Glass are currently loss-making, rendering their multiples less meaningful, but they highlight the spectrum of valuation risk within the sector.

Saint-Gobain Sekurit, despite being labelled "very expensive," still trades at nearly half Borosil’s P/E ratio, underscoring the latter’s stretched valuation. The PEG ratio for Borosil Scientific is reported as 0.00, which may indicate a lack of meaningful earnings growth expectations or data unavailability, further complicating the valuation narrative.

Price Momentum Versus Fundamental Value

Despite the elevated multiples, Borosil Scientific’s share price has shown resilience, with a current price of ₹116.45, up from a previous close of ₹105.75. The stock’s 52-week range spans from ₹99.70 to ₹190.45, indicating significant volatility and a recent pullback from its highs. Today’s intraday trading range between ₹113.10 and ₹126.90 reflects ongoing investor interest but also heightened uncertainty.

Investors should weigh the recent price gains against the deteriorating valuation metrics and subdued return ratios. The stock’s Mojo Score of 45.0 and a downgrade in Mojo Grade from Strong Sell to Sell on 11 Feb 2026 signal a cautious stance from market analysts, suggesting limited upside potential without fundamental improvement.

Outlook and Investor Considerations

Given the current valuation profile, investors should approach Borosil Scientific with caution. The elevated P/E and EV multiples, combined with modest profitability and return metrics, suggest that the stock is priced for perfection. Any earnings disappointment or sectoral headwinds could trigger sharp corrections. The lack of dividend yield further reduces the stock’s attractiveness for income-seeking investors.

Comparative analysis indicates that more attractively valued peers with stronger fundamentals exist within the industrial products sector. Investors may benefit from considering these alternatives, especially those with lower multiples and higher return ratios, to optimise portfolio risk and return profiles.

In summary, while Borosil Scientific has demonstrated short-term price strength, the shift from fair to expensive valuation grades and the downgrade in Mojo Grade to Sell highlight the need for prudence. Monitoring earnings trends, sector developments, and valuation re-rating will be critical for investors contemplating exposure to this stock.

Unlock special upgrade rates for a limited period. Start Saving Now →